Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Among all the neurogenic tumours, the benign intrathoracic schwannoma is a rare tumour. Most often it is discovered by accident in the course of a routine X-ray examination of the thorax. Symptoms appear only when size becomes important. The surgical removal of an intrathoracic schwannoma may result in the development of a
chylothorax
. According to the literature, its treatment remains controversial. The originality of the case we report here is on the one hand the exceptional size of the tumour and the success over the long term of conservative treatment with complete parenteral alimentation, and on the other hand, the inefficacy of the subcutaneous administration of the analogue of
somatostatin
in reducing a
chylothorax
with high outflow.
...
PMID:Benign thoracic schwannoma and postoperative chylothorax: case report and review of the literature. 801 50
Chylothorax
is a rare but potentially serious complication of pediatric cardiac operations. We report the case of a 4-month-old boy who underwent a Senning procedure for correction of D-transposition of the great vessels. A persistent postoperative
chylothorax
developed, necessitating continuous drainage, despite conservative treatment over 3 weeks. Thereafter, continuous
somatostatin
infusion for 14 days led to the reduction and finally cessation of chyle production. This treatment allowed early enteral feeding and avoided further surgical intervention.
...
PMID:Treatment of a persistent postoperative chylothorax with somatostatin. 969 78
Chylothorax
is a rare but serious postoperative complication of thoracic surgical procedures. We report the case of a 77-year-old man who underwent a coronary artery bypass procedure using a left internal mammary artery pedicle graft. A permanent pacemaker was required postoperatively. A persistent postoperative
chylothorax
developed necessitating continuous drainage and conservative management.
Somatostatin
was instituted when after 1 week this management failed to resolve the
chylothorax
. This led to rapid cessation of chyle production. Enteral feeding was reinstituted without complication and surgical intervention was avoided.
...
PMID:Conservative management of postoperative chylothorax using somatostatin. 1089 58
Chylothorax
is a serious condition with a high rate of morbidity that may lead to death. Although it is encountered more frequently with certain thoracic procedures, it is considered to be a rare complication of neck dissection. Different forms of management have been postulated; however, no consensus of treatment has been achieved. A case of severe bilateral
chylothorax
that developed after bilateral neck dissection in a patient with laryngeal carcinoma is presented.
Somatostatin
injection was successful after total parenteral nutrition failed to control the
chylothorax
. On the basis of this case and the review of the literature discussed here, we advocate the use of
somatostatin
with other conservative measures in the management of
chylothorax
.
...
PMID:Bilateral chylothorax following neck dissection: a new method of treatment. 1130 17
Chylothorax
after pediatric cardiac operations is associated with significant morbidity and increased hospitalization. An octreotide (a synthetic
somatostatin
analogue) infusion (1 to 4 microg/kg per hour) with medium-chain triglyceride diet or parenteral nutrition was used in 4 pediatric cardiac surgical patients after
chylothorax
was diagnosed. Resolution followed within 5 days in all without recurrence, while on a normal diet.
...
PMID:Octreotide to treat postoperative chylothorax after cardiac operations in children. 1172 81
A newborn who had undergone Norwood procedure for hypoplastic left heart syndrome developed a voluminous
chylothorax
that persisted despite weeks of prolonged complete bowel rest, total parenteral nutrition, and effective chest tube drainage. Chest tube output diminished immediately following initiation of intravenous
somatostatin
, allowing restoration of full enteral feeds and removal of chest tubes within 6 days.
...
PMID:Treatment of persistent chylothorax after Norwood procedure with somatostatin. 1284 86
Diseases of the lymphatic system in children include a group of exceptional conditions difficult to manage. The anatomy of lymphatic system is complex in the lung. Variable from one subject to another, its complex physiology plays an important role in air-blood exchanges occurring in the lung. In the pulmonary interstitium and in the pleura, the lymphatic system acts like an overflow valve capable of regulating variations in interstitial fluid. The presence or development of dysplasic lymphatics causes leakage, dilatation, and reflux of the lymph through incontinent valves leading to
chylothorax
and/or fluid overload in the pulmonary interstitium. Symptomatic care is usually proposed, based on a fat-free diet supplemented with light-chain triglycerides and liposoluble vitamins. Other therapeutic options can be proposed. Medical options include cytotoxic agents,
somatostatin
, and interferon-alpha. Surgery may also be useful, but an assessment of therapeutic efficacy is very difficult due to partial effects and the small number of cases studied.
...
PMID:[Diseases of the pulmonary lymphatic system in children]. 1271 21
A 2-week-old infant status postrepair of gastroschisis had spontaneous bilateral chylothoraces necessitating thoracostomy drainage. Voluminous chylous drainage persisted despite cessation of enteral feedings. On administration of the
somatostatin
analogue octreotide, pleural drainage diminished markedly and ceased entirely within 4 days. These results, along with reported successes in treatment of
chylothorax
after thoracic surgery, support the prospective investigation of
somatostatin
use in problematic
chylothorax
.
...
PMID:Successful use of somatostatin in a case of neonatal chylothorax. 1286 52
Chylothorax
is a recognized cause of morbidity after repair of congenital diaphragmatic hernia (CDH). Management may include prolonged hospitalization with cessation of enteral feedings, repeated aspiration, chest tube drainage, total parenteral nutrition, and introduction of a medium chain triglyceride (MCT) diet as the effusion resolves. The authors report that the successful deployment of octreotide, a
somatostatin
analogue, hastened resolution of a postoperative
chylothorax
in a newborn infant with CDH.
...
PMID:Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia. 1289 19
Thymectomy has been shown to be effective in the treatment of myasthenia gravis patients. Rarely, bilateral
chylothorax
, was noted as a complication of thymectomy via median sternotomy. Probably unseen division of mediastinal lymphatics, remote from thoracic duct, can explain this phenomenon. We report the case of a patient, female, who developed bilateral
chylothorax
after the former surgical approach, and our initial conservative policy to treat it (unilateral chest tube, total parenteral nutrition and subcutaneous administration of octreotide, a long-acting
somatostatin
analog), with good results.
...
PMID:Bilateral chylothorax after thymectomy via median sternotomy and resolution through conservative treatment. 1296 26
1
2
3
4
5
6
Next >>